Literature DB >> 15958446

Treatment of liver metastases of colorectal cancer.

J Rothbarth1, C J H van de Velde.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15958446     DOI： 10.1093/annonc/mdi702

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  31 in total

1.  Enzymatic function of multiple origins regulates the progression of colorectal cancer and the development of metastases.

Authors:  K A Paschos; D Canovas; N C Bird
Journal:  Hippokratia       Date:  2009-01       Impact factor: 0.471

2.  Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases.

Authors:  Maximilian Bockhorn; Georgios Sotiropoulos; Jan Neuhaus; George Sgourakis; Sien-Yi Sheu; Ernesto Molmenti; Christian Fingas; Tanja Trarbach; Andreja Frilling; Christoph E Broelsch
Journal:  Int J Colorectal Dis       Date:  2009-02-25       Impact factor: 2.571

3.  Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis.

Authors:  Pengcheng Bu; Kai-Yuan Chen; Kun Xiang; Christelle Johnson; Scott B Crown; Nikolai Rakhilin; Yiwei Ai; Lihua Wang; Rui Xi; Inna Astapova; Yan Han; Jiahe Li; Bradley B Barth; Min Lu; Ziyang Gao; Robert Mines; Liwen Zhang; Mark Herman; David Hsu; Guo-Fang Zhang; Xiling Shen
Journal:  Cell Metab       Date:  2018-04-26       Impact factor: 27.287

4.  Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival.

Authors:  A Veltri; T Guarnieri; C Gazzera; M Busso; F Solitro; G Fora; P Racca
Journal:  Radiol Med       Date:  2012-03-19       Impact factor: 3.469

5.  Serological diagnostic factors for liver metastasis in patients with colorectal cancer.

Authors:  Xiong-Zhi Wu; Feng Ma; Xue-Lin Wang
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

6.  Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer.

Authors:  S Gill; S Berry; J Biagi; C Butts; M Buyse; E Chen; D Jonker; C Mărginean; B Samson; J Stewart; M Thirlwell; R Wong; J A Maroun
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

7.  Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies.

Authors:  John D Roberson Ii; Andrew M McDonald; Craig J Baden; Chee Paul Lin; Rojymon Jacob; Omer L Burnett Iii
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

8.  Prognostic value of β1 integrin expression in colorectal liver metastases.

Authors:  Nikolaos Vassos; Tilman Rau; Susanne Merkel; Fabian Feiersinger; Carol I Geppert; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

9.  Survival of patients with synchronous and metachronous colorectal liver metastases--is there a difference?

Authors:  Maximilian Bockhorn; Andreja Frilling; Nils R Frühauf; Jan Neuhaus; Ernesto Molmenti; Tanja Trarbach; Massimo Malagó; Hauke Lang; Christoph E Broelsch
Journal:  J Gastrointest Surg       Date:  2008-06-03       Impact factor: 3.452

10.  Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis.

Authors:  K A Paschos; N Bird
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.